Liaoning Medya PharmaceuticalCo.,Ltd.is a Sino—foreign joint venture,founded in 2002.The former of the company is Fushun Medjohn Pharmaceutical Co.,Ltd.,which was established in 1996,one of the earliest enterprises specializing in Cephalosporin intermediates in china .The shareholders of the company are Shanghai New Asiatic Pharmaceutical Co.Ltd.,Super Links Hong Kong Co.Ltd.
The registered capital is 1.3hundred million RMBs.Now the company owns 400 employees occupies 114,000m2. The are two production zones located in different places.One is the intermediates production zone, its area is 34,000 m2,the products are Cephalosporin intermediates other ones, passed ISO9001:2000 certification in 2003.The other production zone is APIs one,its area is 80,000 m2,the main products are sterile APIs which were passed Chinese drug GMP certification in Feb,2005.
There are five synthetic workshops,one sterile workshop(including six sterile APIs production lines).We have the capability of producing intermediates(700 tons per year) Cephalosporin sterile(300 tons per year).
The intermediates have been produced sold since 1996,the countries where the intermediates were exported are Engl ,Austria, France, Italy , Germany,Spain,South Korea,etc.
Most of the core leaderships graduated from the famous Shenyang Pharmceutical College of china,who have worked in pharmceuticals for more than 20 years,are rich of experiences in drug APIs production,quality management sale.We insist on the principle of general manager responsible for the enterprise under the leading of the board the directors.In products management we observe Chinses current GMP,ICH GMP guidance for APIs, FDAcGMP guidance for sterile drugs produced by aseptic processing other concerned technical stards(USP,EP etc.)